カテゴリ： QYResearch, 世界, 産業機械/建設

バイオ医薬品サービスの世界市場2023年：原材料、製造工程・製品、医薬品完成品、その他

■ 英語タイトル：Global BioPharma Service Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA4931）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA4931
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：産業機械
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[バイオ医薬品サービスの世界市場2023年：原材料、製造工程・製品、医薬品完成品、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はバイオ医薬品サービスのグローバル市場について調査・分析し、世界のバイオ医薬品サービス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（原材料、製造工程・製品、医薬品完成品、その他）、用途別セグメント分析（分析試験、医薬品開発サービス、医薬品包装＆配送、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Eurofins、Pace Analytical Services、Catalent、Envigo、PPD、Element、ALS、Intertek、SGS、Boston Analytical、EAG、Maxxam、ARL Bio Pharma、West Pharmaceutical、BioScreen、Microbac、RD Laboratories、Analytical Lab Group、Piramal Pharma Solutionsなどが含まれています。バイオ医薬品サービスのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、バイオ医薬品サービス市場規模を算出する際に考慮しました。

・バイオ医薬品サービス市場の概要
- バイオ医薬品サービスの種類別セグメント
- 世界のバイオ医薬品サービス市場規模：タイプ別分析（原材料、製造工程・製品、医薬品完成品、その他）
- バイオ医薬品サービスの用途別セグメント
- 世界のバイオ医薬品サービス市場規模：用途別分析（分析試験、医薬品開発サービス、医薬品包装＆配送、その他）
- 世界のバイオ医薬品サービス市場規模予測（2018年-2029年）

・バイオ医薬品サービス市場の成長トレンド
- バイオ医薬品サービスの地域別市場規模（2018年-2029年）
- バイオ医薬品サービス市場ダイナミクス
- バイオ医薬品サービスの業界動向
- バイオ医薬品サービス市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：原材料、製造工程・製品、医薬品完成品、その他
- 世界のバイオ医薬品サービスのタイプ別市場規模（2018年-2023年）
- 世界のバイオ医薬品サービスのタイプ別市場規模（2024年-2029年）

・用途別セグメント：分析試験、医薬品開発サービス、医薬品包装＆配送、その他
- 世界のバイオ医薬品サービスの用途別市場規模（2018年-2023年）
- 世界のバイオ医薬品サービスの用途別市場規模（2024年-2029年）

・バイオ医薬品サービスの地域別市場規模
- 北米のバイオ医薬品サービス市場規模（2018年-2029年）
- 米国のバイオ医薬品サービス市場規模（2018年-2029年）
- ヨーロッパのバイオ医薬品サービス市場規模（2018年-2029年）
- アジア太平洋のバイオ医薬品サービス市場規模（2018年-2029年）
- 中国のバイオ医薬品サービス市場規模（2018年-2029年）
- 日本のバイオ医薬品サービス市場規模（2018年-2029年）
- 韓国のバイオ医薬品サービス市場規模（2018年-2029年）
- インドのバイオ医薬品サービス市場規模（2018年-2029年）
- オーストラリアのバイオ医薬品サービス市場規模（2018年-2029年）
- 中南米のバイオ医薬品サービス市場規模（2018年-2029年）
- 中東・アフリカのバイオ医薬品サービス市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Eurofins、Pace Analytical Services、Catalent、Envigo、PPD、Element、ALS、Intertek、SGS、Boston Analytical、EAG、Maxxam、ARL Bio Pharma、West Pharmaceutical、BioScreen、Microbac、RD Laboratories、Analytical Lab Group、Piramal Pharma Solutions

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global BioPharma Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for BioPharma Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for BioPharma Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for BioPharma Service in Analytical Testing is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of BioPharma Service include Eurofins, Pace Analytical Services, Catalent, Envigo, PPD, Element, ALS, Intertek and SGS, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for BioPharma Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BioPharma Service.
The BioPharma Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global BioPharma Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BioPharma Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Eurofins
Pace Analytical Services
Catalent
Envigo
PPD
Element
ALS
Intertek
SGS
Boston Analytical
EAG
Maxxam
ARL Bio Pharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions
Segment by Type
Raw Material
In-Process and Product
Finished Pharmaceutical
Others
Segment by Application
Analytical Testing
Drug Development Service
Drug Packaging and Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BioPharma Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global BioPharma Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Raw Material
1.2.3 In-Process and Product
1.2.4 Finished Pharmaceutical
1.2.5 Others
1.3 Market by Application
1.3.1 Global BioPharma Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Analytical Testing
1.3.3 Drug Development Service
1.3.4 Drug Packaging and Delivery
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global BioPharma Service Market Perspective (2018-2029)
2.2 BioPharma Service Growth Trends by Region
2.2.1 Global BioPharma Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 BioPharma Service Historic Market Size by Region (2018-2023)
2.2.3 BioPharma Service Forecasted Market Size by Region (2024-2029)
2.3 BioPharma Service Market Dynamics
2.3.1 BioPharma Service Industry Trends
2.3.2 BioPharma Service Market Drivers
2.3.3 BioPharma Service Market Challenges
2.3.4 BioPharma Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top BioPharma Service Players by Revenue
3.1.1 Global Top BioPharma Service Players by Revenue (2018-2023)
3.1.2 Global BioPharma Service Revenue Market Share by Players (2018-2023)
3.2 Global BioPharma Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by BioPharma Service Revenue
3.4 Global BioPharma Service Market Concentration Ratio
3.4.1 Global BioPharma Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BioPharma Service Revenue in 2022
3.5 BioPharma Service Key Players Head office and Area Served
3.6 Key Players BioPharma Service Product Solution and Service
3.7 Date of Enter into BioPharma Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 BioPharma Service Breakdown Data by Type
4.1 Global BioPharma Service Historic Market Size by Type (2018-2023)
4.2 Global BioPharma Service Forecasted Market Size by Type (2024-2029)
5 BioPharma Service Breakdown Data by Application
5.1 Global BioPharma Service Historic Market Size by Application (2018-2023)
5.2 Global BioPharma Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America BioPharma Service Market Size (2018-2029)
6.2 North America BioPharma Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America BioPharma Service Market Size by Country (2018-2023)
6.4 North America BioPharma Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe BioPharma Service Market Size (2018-2029)
7.2 Europe BioPharma Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe BioPharma Service Market Size by Country (2018-2023)
7.4 Europe BioPharma Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific BioPharma Service Market Size (2018-2029)
8.2 Asia-Pacific BioPharma Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific BioPharma Service Market Size by Region (2018-2023)
8.4 Asia-Pacific BioPharma Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America BioPharma Service Market Size (2018-2029)
9.2 Latin America BioPharma Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America BioPharma Service Market Size by Country (2018-2023)
9.4 Latin America BioPharma Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa BioPharma Service Market Size (2018-2029)
10.2 Middle East & Africa BioPharma Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa BioPharma Service Market Size by Country (2018-2023)
10.4 Middle East & Africa BioPharma Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins
11.1.1 Eurofins Company Detail
11.1.2 Eurofins Business Overview
11.1.3 Eurofins BioPharma Service Introduction
11.1.4 Eurofins Revenue in BioPharma Service Business (2018-2023)
11.1.5 Eurofins Recent Development
11.2 Pace Analytical Services
11.2.1 Pace Analytical Services Company Detail
11.2.2 Pace Analytical Services Business Overview
11.2.3 Pace Analytical Services BioPharma Service Introduction
11.2.4 Pace Analytical Services Revenue in BioPharma Service Business (2018-2023)
11.2.5 Pace Analytical Services Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent BioPharma Service Introduction
11.3.4 Catalent Revenue in BioPharma Service Business (2018-2023)
11.3.5 Catalent Recent Development
11.4 Envigo
11.4.1 Envigo Company Detail
11.4.2 Envigo Business Overview
11.4.3 Envigo BioPharma Service Introduction
11.4.4 Envigo Revenue in BioPharma Service Business (2018-2023)
11.4.5 Envigo Recent Development
11.5 PPD
11.5.1 PPD Company Detail
11.5.2 PPD Business Overview
11.5.3 PPD BioPharma Service Introduction
11.5.4 PPD Revenue in BioPharma Service Business (2018-2023)
11.5.5 PPD Recent Development
11.6 Element
11.6.1 Element Company Detail
11.6.2 Element Business Overview
11.6.3 Element BioPharma Service Introduction
11.6.4 Element Revenue in BioPharma Service Business (2018-2023)
11.6.5 Element Recent Development
11.7 ALS
11.7.1 ALS Company Detail
11.7.2 ALS Business Overview
11.7.3 ALS BioPharma Service Introduction
11.7.4 ALS Revenue in BioPharma Service Business (2018-2023)
11.7.5 ALS Recent Development
11.8 Intertek
11.8.1 Intertek Company Detail
11.8.2 Intertek Business Overview
11.8.3 Intertek BioPharma Service Introduction
11.8.4 Intertek Revenue in BioPharma Service Business (2018-2023)
11.8.5 Intertek Recent Development
11.9 SGS
11.9.1 SGS Company Detail
11.9.2 SGS Business Overview
11.9.3 SGS BioPharma Service Introduction
11.9.4 SGS Revenue in BioPharma Service Business (2018-2023)
11.9.5 SGS Recent Development
11.10 Boston Analytical
11.10.1 Boston Analytical Company Detail
11.10.2 Boston Analytical Business Overview
11.10.3 Boston Analytical BioPharma Service Introduction
11.10.4 Boston Analytical Revenue in BioPharma Service Business (2018-2023)
11.10.5 Boston Analytical Recent Development
11.11 EAG
11.11.1 EAG Company Detail
11.11.2 EAG Business Overview
11.11.3 EAG BioPharma Service Introduction
11.11.4 EAG Revenue in BioPharma Service Business (2018-2023)
11.11.5 EAG Recent Development
11.12 Maxxam
11.12.1 Maxxam Company Detail
11.12.2 Maxxam Business Overview
11.12.3 Maxxam BioPharma Service Introduction
11.12.4 Maxxam Revenue in BioPharma Service Business (2018-2023)
11.12.5 Maxxam Recent Development
11.13 ARL Bio Pharma
11.13.1 ARL Bio Pharma Company Detail
11.13.2 ARL Bio Pharma Business Overview
11.13.3 ARL Bio Pharma BioPharma Service Introduction
11.13.4 ARL Bio Pharma Revenue in BioPharma Service Business (2018-2023)
11.13.5 ARL Bio Pharma Recent Development
11.14 West Pharmaceutical
11.14.1 West Pharmaceutical Company Detail
11.14.2 West Pharmaceutical Business Overview
11.14.3 West Pharmaceutical BioPharma Service Introduction
11.14.4 West Pharmaceutical Revenue in BioPharma Service Business (2018-2023)
11.14.5 West Pharmaceutical Recent Development
11.15 BioScreen
11.15.1 BioScreen Company Detail
11.15.2 BioScreen Business Overview
11.15.3 BioScreen BioPharma Service Introduction
11.15.4 BioScreen Revenue in BioPharma Service Business (2018-2023)
11.15.5 BioScreen Recent Development
11.16 Microbac
11.16.1 Microbac Company Detail
11.16.2 Microbac Business Overview
11.16.3 Microbac BioPharma Service Introduction
11.16.4 Microbac Revenue in BioPharma Service Business (2018-2023)
11.16.5 Microbac Recent Development
11.17 RD Laboratories
11.17.1 RD Laboratories Company Detail
11.17.2 RD Laboratories Business Overview
11.17.3 RD Laboratories BioPharma Service Introduction
11.17.4 RD Laboratories Revenue in BioPharma Service Business (2018-2023)
11.17.5 RD Laboratories Recent Development
11.18 Analytical Lab Group
11.18.1 Analytical Lab Group Company Detail
11.18.2 Analytical Lab Group Business Overview
11.18.3 Analytical Lab Group BioPharma Service Introduction
11.18.4 Analytical Lab Group Revenue in BioPharma Service Business (2018-2023)
11.18.5 Analytical Lab Group Recent Development
11.19 Piramal Pharma Solutions
11.19.1 Piramal Pharma Solutions Company Detail
11.19.2 Piramal Pharma Solutions Business Overview
11.19.3 Piramal Pharma Solutions BioPharma Service Introduction
11.19.4 Piramal Pharma Solutions Revenue in BioPharma Service Business (2018-2023)
11.19.5 Piramal Pharma Solutions Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global BioPharma Service Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Raw Material
Table 3. Key Players of In-Process and Product
Table 4. Key Players of Finished Pharmaceutical
Table 5. Key Players of Others
Table 6. Global BioPharma Service Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global BioPharma Service Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global BioPharma Service Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global BioPharma Service Market Share by Region (2018-2023)
Table 10. Global BioPharma Service Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global BioPharma Service Market Share by Region (2024-2029)
Table 12. BioPharma Service Market Trends
Table 13. BioPharma Service Market Drivers
Table 14. BioPharma Service Market Challenges
Table 15. BioPharma Service Market Restraints
Table 16. Global BioPharma Service Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global BioPharma Service Market Share by Players (2018-2023)
Table 18. Global Top BioPharma Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BioPharma Service as of 2022)
Table 19. Ranking of Global Top BioPharma Service Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by BioPharma Service Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players BioPharma Service Product Solution and Service
Table 23. Date of Enter into BioPharma Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global BioPharma Service Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global BioPharma Service Revenue Market Share by Type (2018-2023)
Table 27. Global BioPharma Service Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global BioPharma Service Revenue Market Share by Type (2024-2029)
Table 29. Global BioPharma Service Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global BioPharma Service Revenue Market Share by Application (2018-2023)
Table 31. Global BioPharma Service Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global BioPharma Service Revenue Market Share by Application (2024-2029)
Table 33. North America BioPharma Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America BioPharma Service Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America BioPharma Service Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe BioPharma Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe BioPharma Service Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe BioPharma Service Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific BioPharma Service Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific BioPharma Service Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific BioPharma Service Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America BioPharma Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America BioPharma Service Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America BioPharma Service Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa BioPharma Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa BioPharma Service Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa BioPharma Service Market Size by Country (2024-2029) & (US$ Million)
Table 48. Eurofins Company Detail
Table 49. Eurofins Business Overview
Table 50. Eurofins BioPharma Service Product
Table 51. Eurofins Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 52. Eurofins Recent Development
Table 53. Pace Analytical Services Company Detail
Table 54. Pace Analytical Services Business Overview
Table 55. Pace Analytical Services BioPharma Service Product
Table 56. Pace Analytical Services Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 57. Pace Analytical Services Recent Development
Table 58. Catalent Company Detail
Table 59. Catalent Business Overview
Table 60. Catalent BioPharma Service Product
Table 61. Catalent Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 62. Catalent Recent Development
Table 63. Envigo Company Detail
Table 64. Envigo Business Overview
Table 65. Envigo BioPharma Service Product
Table 66. Envigo Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 67. Envigo Recent Development
Table 68. PPD Company Detail
Table 69. PPD Business Overview
Table 70. PPD BioPharma Service Product
Table 71. PPD Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 72. PPD Recent Development
Table 73. Element Company Detail
Table 74. Element Business Overview
Table 75. Element BioPharma Service Product
Table 76. Element Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 77. Element Recent Development
Table 78. ALS Company Detail
Table 79. ALS Business Overview
Table 80. ALS BioPharma Service Product
Table 81. ALS Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 82. ALS Recent Development
Table 83. Intertek Company Detail
Table 84. Intertek Business Overview
Table 85. Intertek BioPharma Service Product
Table 86. Intertek Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 87. Intertek Recent Development
Table 88. SGS Company Detail
Table 89. SGS Business Overview
Table 90. SGS BioPharma Service Product
Table 91. SGS Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 92. SGS Recent Development
Table 93. Boston Analytical Company Detail
Table 94. Boston Analytical Business Overview
Table 95. Boston Analytical BioPharma Service Product
Table 96. Boston Analytical Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 97. Boston Analytical Recent Development
Table 98. EAG Company Detail
Table 99. EAG Business Overview
Table 100. EAG BioPharma Service Product
Table 101. EAG Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 102. EAG Recent Development
Table 103. Maxxam Company Detail
Table 104. Maxxam Business Overview
Table 105. Maxxam BioPharma Service Product
Table 106. Maxxam Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 107. Maxxam Recent Development
Table 108. ARL Bio Pharma Company Detail
Table 109. ARL Bio Pharma Business Overview
Table 110. ARL Bio Pharma BioPharma Service Product
Table 111. ARL Bio Pharma Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 112. ARL Bio Pharma Recent Development
Table 113. West Pharmaceutical Company Detail
Table 114. West Pharmaceutical Business Overview
Table 115. West Pharmaceutical BioPharma Service Product
Table 116. West Pharmaceutical Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 117. West Pharmaceutical Recent Development
Table 118. BioScreen Company Detail
Table 119. BioScreen Business Overview
Table 120. BioScreen BioPharma Service Product
Table 121. BioScreen Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 122. BioScreen Recent Development
Table 123. Microbac Company Detail
Table 124. Microbac Business Overview
Table 125. Microbac BioPharma Service Product
Table 126. Microbac Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 127. Microbac Recent Development
Table 128. RD Laboratories Company Detail
Table 129. RD Laboratories Business Overview
Table 130. RD Laboratories BioPharma Service Product
Table 131. RD Laboratories Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 132. RD Laboratories Recent Development
Table 133. Analytical Lab Group Company Detail
Table 134. Analytical Lab Group Business Overview
Table 135. Analytical Lab Group BioPharma Service Product
Table 136. Analytical Lab Group Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 137. Analytical Lab Group Recent Development
Table 138. Piramal Pharma Solutions Company Detail
Table 139. Piramal Pharma Solutions Business Overview
Table 140. Piramal Pharma Solutions BioPharma Service Product
Table 141. Piramal Pharma Solutions Revenue in BioPharma Service Business (2018-2023) & (US$ Million)
Table 142. Piramal Pharma Solutions Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global BioPharma Service Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global BioPharma Service Market Share by Type: 2022 VS 2029
Figure 3. Raw Material Features
Figure 4. In-Process and Product Features
Figure 5. Finished Pharmaceutical Features
Figure 6. Others Features
Figure 7. Global BioPharma Service Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global BioPharma Service Market Share by Application: 2022 VS 2029
Figure 9. Analytical Testing Case Studies
Figure 10. Drug Development Service Case Studies
Figure 11. Drug Packaging and Delivery Case Studies
Figure 12. Others Case Studies
Figure 13. BioPharma Service Report Years Considered
Figure 14. Global BioPharma Service Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global BioPharma Service Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global BioPharma Service Market Share by Region: 2022 VS 2029
Figure 17. Global BioPharma Service Market Share by Players in 2022
Figure 18. Global Top BioPharma Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BioPharma Service as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by BioPharma Service Revenue in 2022
Figure 20. North America BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America BioPharma Service Market Share by Country (2018-2029)
Figure 22. United States BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe BioPharma Service Market Share by Country (2018-2029)
Figure 26. Germany BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific BioPharma Service Market Share by Region (2018-2029)
Figure 34. China BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America BioPharma Service Market Share by Country (2018-2029)
Figure 42. Mexico BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa BioPharma Service Market Share by Country (2018-2029)
Figure 46. Turkey BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia BioPharma Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Eurofins Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 49. Pace Analytical Services Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 50. Catalent Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 51. Envigo Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 52. PPD Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 53. Element Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 54. ALS Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 55. Intertek Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 56. SGS Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 57. Boston Analytical Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 58. EAG Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 59. Maxxam Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 60. ARL Bio Pharma Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 61. West Pharmaceutical Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 62. BioScreen Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 63. Microbac Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 64. RD Laboratories Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 65. Analytical Lab Group Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 66. Piramal Pharma Solutions Revenue Growth Rate in BioPharma Service Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 食品検査サービスの世界市場2023年：ハーブ、ビタミン、ミネラル、アミノ酸、その他
  • 水圧破砕サービスの世界市場2023年：水需要、プロパント需要、化学添加物、その他
  • 腫瘍随伴性天疱瘡治療の世界市場2023年：皮下、静脈内、経口
  • 医薬品契約包装の世界市場2023年：ペットボトル、ブリスターパック、ガラス容器、その他
  • 除染装置＆サービスの世界市場2023年：気化過酸化水素滅菌、ガンマ線照射、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA4931 )"バイオ医薬品サービスの世界市場2023年：原材料、製造工程・製品、医薬品完成品、その他" (英文：Global BioPharma Service Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。